Stockholm - Free Realtime Quote SEK

Nanexa AB (publ) (NANEXA.ST)

Compare
2.2500
+0.0300
+(1.35%)
As of 10:23:46 AM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. David Westberg Chief Executive Officer 2.85M -- 1960
Mr. Marten Rooth Co-Founder, Head of R&D Atomic Layer Deposition and CTO -- -- 1977
Mr. Anders Johansson Co-Founder & Head of Intellectual Property 996k -- 1976
Ms. Cecilia Danckwardt-Lilliestrom Chief Financial Officer -- -- --
Mr. Mikael Asp Head of QA & Expert Sakkunnig -- -- 1962
Mr. Joel Hellrup Head of Pharmaceutical R&D -- -- 1983
Mr. Otto Skolling M.Sc Director of Business Development 867k -- 1961

Nanexa AB (publ)

Virdings Allle 32B
Uppsala, 75450
Sweden
46 18 10 03 00 https://www.nanexa.com
Sector: 
Healthcare
Full Time Employees: 
19

Description

Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

Corporate Governance

Nanexa AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 19, 2025 at 10:59 AM UTC

Nanexa AB (publ) Earnings Date

Recent Events

Related Tickers